Back to ONXX Stock Lookup
Pages: 1 2 3 »» Last Page

ONXX – Analyst Comments

Aug 29, 2013 01:15 PM Amgen (AMGN) PT Lifted to $124 at UBS on Model Update Post Onyx
Aug 26, 2013 01:50 PM Amgen (AMGN) Price Target Raised to $138 at Deutsche Bank
Aug 26, 2013 07:54 AM Amgen (AMGN) Deal for Onyx a Positive on Oncology Expansion & EPS Accretion - Jefferies
Aug 26, 2013 07:47 AM Amgen's (AMGN) / Onyx (ONXX) Deal Viewed as Strategic Positive
Aug 20, 2013 09:59 AM UPDATE: Amgen (AMGN) Seriously Intersted in Onyx (ONXX); Maxim Upgrades Onyx to Buy
Aug 19, 2013 04:52 PM Onyx (ONXX) $130 Takeout Would Not Reflect Oprozomib Potential; Brean Reiterates Buy
Aug 19, 2013 03:09 PM Amgen (AMGN), Onyx (ONXX) Deal Will Go Through Pending New Kyprolis Data
Aug 15, 2013 11:09 AM Onyx (ONXX) / Amgen (AMGN) Deal Probably Will Happen, Says Deutsche Bank
Aug 9, 2013 11:53 AM Canaccord Keeps Onyx Pharma (ONXX) at Buy; Kyprolis Key, But M&A Next Catalyst
Aug 2, 2013 08:25 AM Jefferies Cuts Onyx (ONXX) to Hold, Sees Limited Upside
Jul 22, 2013 06:44 AM Onyx (ONXX) Stock Has M&A 'Baked In'; Deutsche Bank Cuts to Hold
Jul 5, 2013 12:25 PM JP Morgan's Top Stock Picks for 2nd-Half of 2013 (FB) (AAPL) (RYL) (more...)
Jul 1, 2013 02:41 PM Brean Capital Boosts Onyx Pharma (ONXX) Price Target to $160
Jul 1, 2013 11:59 AM Ligand Pharma (LGND) Swings Higher, but Upside Could Be Limited
Jul 1, 2013 09:34 AM Leerink Swann Raies Onyx (ONXX) Price Target to $140
Jun 19, 2013 08:57 AM Kyprolis Sales On-Track (ONXX) - Jefferies
May 20, 2013 11:00 AM Brean Capital Raises Onyx (ONXX) Price Target to $115
Mar 19, 2013 06:50 AM Jefferies Lifts PT on Onyx Pharmaceuticals (ONXX) to $104
Mar 11, 2013 07:18 AM Jefferies Positive on Onyx Pharmaceuticals (ONXX) after NCCN Compendia Listing For Frontline Kyprolis
Feb 22, 2013 08:12 AM Jefferies Trims PT on Onyx Pharmaceuticals (ONXX) Post Q4
Feb 8, 2013 06:57 AM Approval of Celgene's (CELG) Pomalyst Largely Expected by Street (ONXX)
Jan 4, 2013 07:52 AM Onyx Pharma's (ONXX) Kyprolis 'Killin It'
Dec 12, 2012 08:15 AM Onyx Pharmaceuticals (ONXX) May Have Untapped Opportunity in Frontline Multiple Myeloma
Nov 2, 2012 09:34 AM Baird Slaps $99 Price Target on Onyx Pharmaceuticals (ONXX)
Sep 4, 2012 08:23 AM Baird Reiterates an 'Outperform' on Onyx Pharmaceuticals (ONXX); Raising Kyprolis Estimates
Aug 28, 2012 01:18 PM Onyx's (ONXX) Myeloma Drug Might be used for Earlier Stage Treatments
Aug 21, 2012 07:12 AM Jefferies Reiterates a 'Buy' on Onyx Pharmaceuticals (ONXX); Predicting Strong Kyprolis Launch
Aug 16, 2012 03:29 PM Onyx Pharmaceuticals (ONXX) Is Trading at Pre-Kyprolis Approval Levels; Is It Time to Buy?
Aug 14, 2012 09:52 AM Griffin Securities Reiterates a 'Buy' on Ligand Pharma (LGND); Investors Jumped The Gun...Attractive Opportunity
Aug 2, 2012 07:23 AM Baird Reiterates an 'Outperform' on Onyx Pharmaceuticals (ONXX); Kyprolis Uptake and Take-out Potential
Jul 23, 2012 10:25 AM Baird Reiterates an 'Outperform' on Onyx Pharmaceuticals (ONXX); FDA approval of Kyprolis and Increased Takeover Chatter
Jul 23, 2012 08:41 AM Cantor Fitzgerald Maintains a 'Buy' on Ligand Pharma (LGND); Key Partnered Drug is Approved
Jul 23, 2012 08:37 AM Deutsche Bank Maintains a 'Buy' on Onyx Pharmaceuticals (ONXX); SEARCH Fails, But Success Wasn't Necessary
Jul 19, 2012 09:27 AM Deutsche Bank Sees $21 of Upside in Onyx (ONXX) Shares If Kyprolis Pricing Inline with Velcade
Jul 10, 2012 10:48 AM Deutsche Bank Reiterates a 'Buy' on Onyx Pharmaceuticals (ONXX); Expert Weigh In on DECISION
Jun 28, 2012 09:08 AM Brean Murray Raises PT on Onyx Pharma (ONXX); FDA Grants Regorafenib Priority Review; Takeout Speculation Looms
Jun 26, 2012 07:22 AM Deutsche Bank Raises Price Target on Onyx Pharmaceuticals (ONXX); Adding M&A Scenario
Jun 21, 2012 03:54 PM Barclays Raises Price Target on Onyx Pharmaceuticals (ONXX); Kyprolis Gets Surprisingly Supportive Commentary
Jun 21, 2012 10:24 AM Jefferies Adjusts Estimates and Price Target on Onyx Pharmaceuticals (ONXX); Downside Scenarios Reviewed
Jun 21, 2012 07:02 AM Goldman Sachs Raises Price Target on Onyx Pharma (ONXX) after FDA Panel Backs CFZ
Jun 13, 2012 09:08 AM Baird Maintains a 'Neutral' on Onyx Pharmaceuticals (ONXX); Continue Warming Up To Kyprolis
Jun 4, 2012 07:25 AM Jefferies Said Onyx Pharmaceuticals (ONXX) ASCO Data Confirm Concerns On Carf Regulatory Outlook
May 22, 2012 09:46 AM Baird Reiterates a 'Neutral' on Onyx Pharmaceuticals (ONXX); Nexavar Miss Not Real Issue; Kyprolis Remains Focus
May 3, 2012 03:13 PM Barclays Maintains an 'Equalweight' on Onyx Pharmaceuticals (ONXX); Facing Uphill Battle
Mar 26, 2012 02:00 PM Barclays Maintains an 'Equalweight' on Onyx Pharmaceuticals (ONXX); $4 Upside if MISSION Works
Mar 7, 2012 11:26 AM Rodman & Renshaw Says Onyx (ONXX) Shares Undervalued; Reiterates Outperform, $57 Price Target
Feb 23, 2012 09:59 AM Canaccord Genuity Maintains a 'Buy' on Onyx Pharmaceuticals (ONXX); Year-end Nexavar Sales Beat
Jan 26, 2012 11:20 AM Canaccord Genuity on Life Sciences/Biotechnology: Forex Exposure - Impact ITMN, PLX, AEGR & ONXX
Jan 26, 2012 09:23 AM Canaccord Genuity Maintains a 'Buy' on Onyx Pharmaceuticals (ONXX); 2012 Catalyst Highlights
Jan 13, 2012 09:06 AM Canaccord Biotech Meeting Takeaways Part II: NPSP, ONXX, TSRX, & VICL
Pages: 1 2 3 »» Last Page

Back to ONXX Stock Lookup